Peptide drug development has made great progress in the last decade thanks to new
production, modification, and analytic technologies. Peptides have been produced and …

This review discusses peptide epitopes used as antigens in the development of vaccines in
clinical trials as well as future vaccine candidates. It covers peptides used in potential …

Epitope-based DNA vaccine development is one application of bioinformatics or in silico
studies, that is, computational methods, including mathematical, chemical, and biological …

There is a vast practice of using antimalarial drugs, RAS inhibitors, serine protease
inhibitors, inhibitors of the RNA-dependent RNA polymerase of the virus and …

At present, much attention is paid to the use of antimicrobial peptides (AMPs) of natural and
artificial origin to combat pathogens. AMPs have several points that determine their …

COVID-19 caused, as of September, 1rst, 2022, 599,825,400 confirmed cases, including
6,469,458 deaths. Currently used vaccines reduced severity and mortality but not virus …

Despite the efficacy of antiviral drug repositioning, convalescent plasma (CP), and the
currently available vaccines against severe acute respiratory syndrome coronavirus 2 …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the latest of the several
viral pathogens that have acted as a threat to human health around the world. Thus, to …

In the growing field of vaccine design for COVID and cancer research, it is essential to
predict accurate peptide binding affinity and immunogenicity. We developed a …

The coronavirus disease 2019 outbreak has become a huge challenge in the human sector
for the past two years. The coronavirus is capable of mutating at a higher rate than other …